Literature DB >> 23047962

Rhabdomyolysis after co-prescription of statin and fusidic acid.

S Kearney1, A S Carr, J McConville, M O McCarron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23047962     DOI： 10.1136/bmj.e6562

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.

Authors:  Anshul Gupta; Jennifer J Harris; Jianrong Lin; James P Bulgarelli; Bruce K Birmingham; Scott W Grimm
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.

Authors:  Thomas Deljehier; Antoine Pariente; Ghada Miremont-Salamé; Françoise Haramburu; Linh Nguyen; Sébastien Rubin; Claire Rigothier; Hélène Théophile
Journal:  Br J Clin Pharmacol       Date:  2018-02-26       Impact factor: 4.335

3.  Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature.

Authors:  Dimitrios Patoulias; Theodoros Michailidis; Thomas Papatolios; Rafael Papadopoulos; Petros Keryttopoulos
Journal:  Case Rep Nephrol       Date:  2017-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.